These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 16690520
1. Fertility status among women treated for aggressive non-Hodgkin's lymphoma. Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, Blumenfeld Z, Abraham A, Manor Y, Shpilberg O, Lishner M. Leuk Lymphoma; 2006 Apr; 47(4):623-7. PubMed ID: 16690520 [Abstract] [Full Text] [Related]
2. Defining the cost of cure: infertility among female survivors of lymphoma. Stern CJ, Seymour JF. Leuk Lymphoma; 2006 Apr; 47(4):574-5. PubMed ID: 16886268 [No Abstract] [Full Text] [Related]
6. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study. Späth-Schwalbe E, Lange C, Genvresse I, Krüger L, Eucker J, Schweigert M, Sezer O, Budach V, Possinger K. Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085 [Abstract] [Full Text] [Related]
9. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice]. van Agthoven M, Wittebol S, Budel LM, Uyl-de Groot CA, Kramer MH. Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):88-93. PubMed ID: 14753131 [Abstract] [Full Text] [Related]
13. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma]. Yuan ZY, Xu RH, He YJ, Guan ZZ. Ai Zheng; 2003 Apr 10; 22(4):393-6. PubMed ID: 12703996 [Abstract] [Full Text] [Related]
14. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P. Ann Oncol; 2012 Jul 10; 23(7):1818-25. PubMed ID: 22228451 [Abstract] [Full Text] [Related]
17. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma. Intragumtornchai T, Sutheesophon J, Sutcharitchan P, Swasdikul D. Leuk Lymphoma; 2000 Apr 10; 37(3-4):351-60. PubMed ID: 10752986 [Abstract] [Full Text] [Related]
18. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. Gómez H, Hidalgo M, Casanova L, Colomer R, Pen DL, Otero J, Rodríguez W, Carracedo C, Cortés-Funes H, Vallejos C. J Clin Oncol; 1998 Jun 10; 16(6):2065-9. PubMed ID: 9626205 [Abstract] [Full Text] [Related]
19. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809. Fisher RI, Dana BW, LeBlanc M, Kjeldsberg C, Forman JD, Unger JM, Balcerzak SP, Gaynor ER, Roy V, Miller T. J Clin Oncol; 2000 May 10; 18(10):2010-6. PubMed ID: 10811664 [Abstract] [Full Text] [Related]
20. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E, Fisher RI. N Engl J Med; 1998 Jul 02; 339(1):21-6. PubMed ID: 9647875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]